James LItalien - AveXis President
President
Dr. James J. LItalien, Ph.D., is Senior Vice President Chief Regulatory and Quality Officer of the company., since July 2015. Before joining company, since 2012, Dr. LItalien served as senior vice president of regulatory affairs and quality assurance for InterMune, Inc. While at InterMune, he oversaw all global regulatory affairs and quality assurance activities in support of its commercial and developmentstage pharmaceutical programs, including the regulatory process for Esbriet, which was granted a breakthrough designation by the U.S. Food and Drug Administration. Prior to that, Dr. LItalien served as vice president of regulatory affairs and quality assurance for Geron Corporation from 2009 until 2012, where he supported developmentstage programs in oncology and stem cell therapy. Before joining Geron, he served as senior vice president of regulatory affairs and quality assurance for Somaxon Pharmaceuticals, Inc. from 2007 to 2009, and held the global position of senior vice president of regulatory affairs and compliance at Ligand Pharmaceuticals, Inc. from 2002 to 2007 since 2015.
| Age | 63 |
| Tenure | 9 years |
| Professional Marks | Ph.D |
| Phone | 847 572-8280 |
| Web | www.avexis.com |
AveXis Management Efficiency
AveXis' management efficiency ratios could be used to measure how well AveXis manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 12 records | PRESIDENT Age | ||
| Deck Slone | Albertsons Companies | 51 | |
| Allen Kelley | Albertsons Companies | 54 | |
| Anuj Dhanda | Albertsons Companies | 61 | |
| John Lorson | Albertsons Companies | 53 | |
| Nicholas Sumas | Village Super Market | 55 | |
| Sharon McCollam | Albertsons Companies | 61 | |
| Joseph Caporella | National Beverage Corp | 64 | |
| Robert Dimond | Albertsons Companies | 58 | |
| Paul Lang | Albertsons Companies | 54 | |
| Janice Mahon | Universal Display | 66 | |
| Robert Sumas | Village Super Market | 83 | |
| Janice DuFour | Universal Display | 58 | |
Management Performance
| Return On Equity | -0.0073 | |||
| Return On Asset | -1.0E-4 |
AveXis Inc Leadership Team
Elected by the shareholders, the AveXis' board of directors comprises two types of representatives: AveXis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AveXis. The board's role is to monitor AveXis' management team and ensure that shareholders' interests are well served. AveXis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AveXis' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Carole Nuechterlein, Independent Director | ||
| Michael Johannesen, Senior Vice President Chief Compliance Officer, General Counsel | ||
| Daniel Welch, Independent Chairman of the Board | ||
| Rick Modi, Senior Vice President Chief Business Officer | ||
| Phillip Donenberg, Principal Financial Officer, Senior Vice President Principal Accounting Officer | ||
| Andrew Knudten, Sr. VP of Manufacturing and Supply Chain | ||
| James LItalien, Senior Vice President - Chief Regulatory and Quality Officer | ||
| Joao Siffert, Director | ||
| Lori Smith, Chief Human Resource Officer, Senior Vice President | ||
| Jim Goff, Vice President Investor Relations and Corporate Communications | ||
| Thomas Dee, CFO and Sr. VP | ||
| Jonathan Leff, Independent Director | ||
| Sukumar Nagendran, Senior Vice President and Chief Medical Officer | ||
| Terrence Kearney, Independent Director | ||
| Frank Verwiel, Independent Director | ||
| Bong Koh, Independent Director | ||
| Brian Kaspar, Chief Scientific Officer, Member of Scientific Advisory Board and Director | ||
| Sukumar MD, Chief Medical Officer and Sr. VP | ||
| Sean Nolan, CEO and President and Director | ||
| Paul Manning, Independent Director | ||
| Session, Senior Vice President - Corporate Strategy and Project Management |
AveXis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AveXis a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0073 | |||
| Return On Asset | -1.0E-4 | |||
| Current Valuation | 7.43 B | |||
| Shares Outstanding | 36.82 M | |||
| Shares Owned By Insiders | 16.87 % | |||
| Shares Owned By Institutions | 83.26 % | |||
| Number Of Shares Shorted | 3.99 M | |||
| Price To Earning | (20.13) X | |||
| Price To Book | 21.01 X | |||
| EBITDA | (218.1 M) |
Pair Trading with AveXis
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AveXis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AveXis will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in AveXis Stock
If you are still planning to invest in AveXis Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AveXis' history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |